Deep Brain Stimulation for Movement Disorders: What the Implant Changes Day to Day

The coffee cup gives it away. Not the tremor itself, which he has learned to hide by keeping his right hand in a pocket, but the way he now waits for his wife to pour, because a full mug is a gamble. His neurologist has said the words he half expected and half dreaded: it may be time to talk about deep brain stimulation for movement disorders. He has a picture in his head of wires and a whirring machine. The reality is quieter, and stranger.

Roughly the size of a matchbox, the pulse generator sits under the skin below the collarbone. Two leads thinner than spaghetti run under the scalp to targets deep in the brain no bigger than a pea. Nothing whirs. Most people cannot feel it working at all. What they notice is the mug arriving at their lips without a detour.

This article walks through what the implant actually does, who is usually offered it, what the first weeks involve, and, just as honestly, what it leaves unchanged.

How does deep brain stimulation work for movement disorders?

Start with what a movement disorder is at the level of wiring. Deep inside the brain sit the basal ganglia, a cluster of structures that act like a traffic-control system for movement, deciding which motions get a green light and which are suppressed. In Parkinson’s disease, essential tremor and dystonia, that traffic system falls into abnormal rhythms. Some circuits fire too much, some too little, and some fall into a lockstep oscillation that shows up in the hand as a shake or in the neck as a twist.

Deep brain stimulation, usually shortened to DBS, does not repair those circuits. It overrides them. A surgeon places a lead, a flexible insulated wire with several metal contacts at its tip, into a precise spot within the affected circuit. An extension wire runs under the skin of the scalp and neck to a pulse generator, a sealed battery-powered device implanted in the chest. The generator sends a steady train of tiny electrical pulses, typically more than a hundred per second, to the contacts. That constant input disrupts the abnormal firing pattern, much as a steady hum can mask an irregular rattle.

The exact mechanism is still debated. Mayo Clinic’s patient guide describes the pulses as regulating abnormal impulses, and NIH’s National Institute of Neurological Disorders and Stroke notes that stimulation can affect cells and chemicals in the brain in ways researchers continue to study. The practical point for patients is that the effect is adjustable and reversible. A clinician with a handheld programmer can change which contact is active and how strong the pulse is, and the device can be turned off entirely. That reversibility is the main reason DBS displaced the older approach of permanently destroying a small piece of brain tissue.

Which movement disorders is DBS used for?

Three conditions account for most DBS procedures worldwide, and each responds in a slightly different way.

Parkinson’s disease is the most common reason. Here the goal is to reduce the motor symptoms that respond to levodopa, the medication that replaces dopamine in the brain, while smoothing out the peaks and troughs that build up after years of treatment. Tremor, rigidity and slowness usually respond; the NHS notes that DBS is generally considered when medication no longer gives adequate control.

Essential tremor is a shaking, most often of the hands, that appears during action rather than at rest and is not caused by Parkinson’s. Tremor is the symptom DBS addresses most reliably, and the target is a relay station in the thalamus, a structure that hands sensory and motor signals between deeper brain regions and the cortex.

Dystonia means sustained or repetitive muscle contractions that force part of the body into abnormal postures or twisting movements. It may affect one region, such as the neck, or the whole body, and it can be inherited or acquired. DBS is an established option when injections and oral medicines fall short, particularly for generalized inherited forms. Cleveland Clinic’s overview points out that benefit in dystonia often builds gradually over months rather than appearing at once.

DBS is also studied, and in some countries approved, for conditions outside the movement-disorder family, including severe epilepsy and treatment-resistant obsessive-compulsive disorder. Those uses follow different rules and different targets and are outside the scope of this article. For Tourette syndrome and several rarer movement disorders, the evidence remains limited, and mainstream guidance treats DBS there as investigational rather than routine.

Who is usually offered deep brain stimulation for movement disorders, and who is asked to wait?

Selection matters more than surgical skill in determining how someone fares, and specialist teams spend weeks on it. The picture below reflects the criteria described by Mayo Clinic, Cleveland Clinic and the NHS; individual programs vary, and the final call always rests with the treating team.

For Parkinson’s disease, the strongest single predictor of benefit is how well someone still responds to levodopa. Symptoms that improve when the medication is working are the ones most likely to improve with stimulation. Candidates typically have had the diagnosis for several years, still have clear “on” periods, and struggle with fluctuations, disabling tremor or troublesome involuntary movements despite careful medication adjustment. Many programs conduct a formal test in which the person is examined both off medication and after a dose to measure that response.

People are usually asked to wait, or steered elsewhere, when:

• Symptoms remain reasonably controlled with medication, because surgery carries risks that are hard to justify when the current plan works.
• The diagnosis is uncertain, or features suggest an atypical parkinsonian syndrome, which tends not to respond to DBS.
• Significant memory or thinking difficulties are present, since stimulation may worsen cognition and the demands of programming and follow-up are considerable.
• Untreated depression, psychosis or unstable mood is present; teams often ask for these to be treated first.
• Medical conditions make general anesthesia or a lengthy operation unsafe, or imaging shows changes that make lead placement risky.

For essential tremor, candidates have tremor that limits eating, writing or dressing despite trying standard medicines. For dystonia, the conversation usually opens after botulinum toxin injections and oral options have not delivered enough relief, and genetic subtype can influence expected benefit. Age alone is rarely a bar; overall health and goals carry more weight.

What happens during DBS surgery for Parkinson's and other movement disorders?

Most people are surprised to learn that the operation is often done in two parts, and that they may be awake for one of them.

Before surgery, a detailed MRI maps the brain. On the day, or shortly before, the surgeon fixes a lightweight frame or small anchoring pins to the skull and takes a CT scan; merging the two images gives coordinates for the target to within about a millimeter.

Placing the leads is the first stage. The scalp is numbed and one or two small openings, roughly the size of a coin, are made in the skull. Many centers keep the person awake at this point, because the brain itself has no pain receptors and a conscious patient can report what happens as the surgeon tests stimulation. Some teams use microelectrode recording, a technique that listens to the crackle of individual brain cells to confirm the electrode is in the right neighborhood. Increasingly, centers offer the whole procedure under general anesthesia with real-time imaging instead; Mayo Clinic describes both approaches as options depending on the program and the patient. Neither has been shown by mainstream guidance to be clearly superior for everyone.

Implanting the generator is the second stage. Under general anesthesia, a pocket is made beneath the skin of the upper chest and the extension wire is tunneled under the skin of the neck to connect lead and battery. This may happen the same day or a week or two later.

Cleveland Clinic’s patient information describes a hospital stay of one to two days after lead placement. Most people go home with dissolvable or removable stitches at the scalp and chest, a headache that eases over days, and, crucially, a device that is usually still switched off. What the surgeon has built is a tool; the tuning comes later.

Where do the electrodes go? The three main DBS targets

The choice of target is one of the most consequential decisions the team makes, and it shapes what changes day to day. Each region is a few millimeters across, buried several centimeters beneath the surface of the brain.

Target	Plain-language role	Mainly used for	What patients often notice
Subthalamic nucleus (STN)	A small hub that acts as a brake within the movement circuit	Parkinson’s disease	Improved tremor, stiffness and slowness; often allows medication reduction, which in turn eases dyskinesia
Globus pallidus interna (GPi)	An output station that shapes the final “go/stop” signal	Parkinson’s disease, dystonia	Direct reduction of dyskinesia and dystonic posturing; medication changes tend to be smaller
Ventral intermediate nucleus of the thalamus (VIM)	A relay that carries movement signals to the cortex	Essential tremor, tremor-dominant Parkinson’s	Marked reduction in tremor, with less effect on stiffness or slowness

For Parkinson’s disease, STN and GPi are both established targets, and large comparative trials summarized by NIH have not shown one to be clearly better overall. Teams weigh trade-offs: STN stimulation is more often associated with medication reduction and with mood or speech effects, while GPi may be favored when dyskinesia dominates or when cognition is a concern. Johns Hopkins’ patient material notes that the target is chosen for each person based on their most troublesome symptoms.

Leads are usually placed on both sides of the brain for Parkinson’s and dystonia, because symptoms typically affect both sides of the body. For essential tremor, a single lead on the side opposite the dominant hand is sometimes enough, with a second considered later if needed. Each side of the brain controls the opposite side of the body, so a left-sided lead helps the right hand.

What do the first weeks after DBS surgery look like?

The honest answer is that the early weeks feel oddly anticlimactic. The hard part, the surgery, is over, yet symptoms may be little changed because the device has not been switched on. Some people even notice a temporary improvement in the first days, a “lesion effect” from mild swelling around the freshly placed lead. It fades, and it is not a preview of the final result.

Days 1 to 14. Headache, scalp tenderness and fatigue are common. Wound care is straightforward: keep incisions clean and dry as instructed, avoid strenuous activity and heavy lifting, and watch for signs of infection. Mild confusion can occur in the first days, especially in older adults, and usually settles. Medication for the underlying condition is generally continued unchanged; any adjustment belongs to the prescribing clinician.

Weeks 2 to 6. Mayo Clinic describes the generator being activated a few weeks after surgery, once swelling has subsided. At that first programming visit, a clinician tests each contact on each lead, watching tremor, stiffness or posture and asking about tingling, pulling sensations or slurred speech. The settings that give the best effect with the fewest side effects become the starting point. Patients are usually sent home with a small handheld controller that lets them check the battery, switch the device on and off, and sometimes choose between a few preset programs.

Months 1 to 6. Programming is iterative. Several visits, often three to six in the first months according to Cleveland Clinic’s patient guidance, are needed to fine-tune stimulation and adjust medication in step. Dystonia sits at the slow end: postures may keep improving for months after settings are stable. Essential tremor sits at the fast end, with change often obvious in the clinic chair. Parkinson’s falls between.

What the implant changes day to day, and what living with the hardware involves

Ask people what DBS changed and they rarely mention a rating scale. They describe mornings.

Before stimulation, a person with advanced Parkinson’s often wakes stiff and slow, waits for the first medication dose to work, enjoys a window of mobility, then feels it slip away before the next dose. That cycle, repeated several times a day, dictates when meals happen, when errands are attempted, when it is safe to be far from a bathroom. Stimulation runs continuously, so it fills in the troughs. The NHS describes the aim as reducing symptoms and the amount of medication needed. For many, that translates into a longer, more predictable good stretch, fewer sudden freezes, and less anxiety about timing.

Tremor is the change that is easiest to see. Handwriting may become legible again; soup returns to the menu. Stiffness eases, which shows up as easier turning in bed and buttoning shirts. Involuntary writhing movements often lessen, partly because medication can sometimes be reduced. In dystonia, the neck may straighten or the foot may stop curling, changes that arrive slowly but alter posture, pain and self-consciousness.

Then there is the hardware. It asks for a little attention:

• Battery. Cleveland Clinic’s patient information describes non-rechargeable generators lasting roughly three to five years before a minor outpatient replacement, while rechargeable models last considerably longer but need regular charging through the skin with a pad.
• Magnets and machines. Household appliances are generally fine. Strong magnets, some security gates and certain medical equipment such as diathermy can interfere; patients carry an identification card and tell every clinician about the device. MRI is possible only under conditions specified for the particular system.
• Travel. Airport scanners may be walked through or bypassed on request; the card helps.
• Driving and work. Decisions depend on symptom control and local rules, and are made with the treating team.

Most people forget the generator is there within weeks. The scalp bumps where the leads are anchored are usually the only reminder.

What DBS does not fix

A seasoned neurologist will spend as much time on this list as on the benefits, because unrealistic hopes are the main source of disappointment after an operation that went perfectly.

Disease progression. DBS treats symptoms; it does not slow the underlying loss of brain cells in Parkinson’s disease. Symptoms that were not present at surgery may appear later, as NIH’s Parkinson’s overview makes clear. The device continues to help with the features it was placed for, but the disease around it moves on.

Symptoms that do not respond to levodopa. A useful rule of thumb from Mayo Clinic’s guidance: what levodopa cannot improve, stimulation usually cannot either. Falls, freezing of gait that persists during “on” time, and stooped posture often fall into this category. Balance may not improve and, for some, can worsen.

Speech and swallowing. Speech can become quieter or less distinct with stimulation, particularly with STN targets. Programming can sometimes trade a little motor benefit for clearer speech, but it is a trade-off, not a fix.

Thinking, mood and sleep. Memory, attention and word-finding are not treated by DBS and may decline slightly afterward, especially in people with pre-existing difficulties. Depression, apathy and impulsive behavior can appear or shift as stimulation and medication change; teams monitor for this. Non-motor features such as constipation, low blood pressure on standing, urinary urgency and loss of smell continue on their own course.

Essential tremor of the head and voice. Hand tremor responds well; head and voice tremor respond less predictably. Some people also notice tremor benefit fading over years, requiring reprogramming, a phenomenon called habituation.

Knowing this list beforehand turns the post-surgery months from a series of surprises into a set of expected adjustments.

Can deep brain stimulation help with dyskinesia?

Dyskinesia refers to the involuntary, flowing or jerky movements that appear in many people with Parkinson’s disease after years of levodopa treatment, typically at the peak of a dose. They are often more distressing to family than to the person experiencing them, yet at their worst they interfere with eating, sitting and sleep. They are also one of the clearest reasons people are referred for DBS, because they mark the point where adjusting medication alone has run out of room: raise the dose and dyskinesia worsens, lower it and stiffness returns.

DBS helps with dyskinesia through two distinct routes, and which one dominates depends on the target.

With stimulation of the globus pallidus interna, the effect is direct. Trials summarized in NIH-indexed literature and in Mayo Clinic’s patient information report that GPi stimulation suppresses dyskinesia itself, often before any change to medication. This is one reason GPi is sometimes preferred when dyskinesia is the dominant complaint.

With stimulation of the subthalamic nucleus, the effect is largely indirect. Because STN stimulation improves the same symptoms levodopa treats, the prescribing clinician can often reduce the medication over subsequent months, and dyskinesia falls with it. If stimulation is set too strong at the STN, it can itself provoke dyskinesia-like movements, which programmers use as a sign to ease back.

Two caveats matter. First, dyskinesia relief is not guaranteed and varies between individuals; teams describe it as a common benefit, not a promised one. Second, any medication reduction is gradual and belongs entirely to the prescribing clinician; reducing medication too quickly after surgery can trigger severe stiffness and, rarely, a dangerous withdrawal state. Patients should never adjust their own regimen in anticipation of stimulation.

For dystonia, a related but different problem, the same GPi target is used, and the twisting postures typically improve over months rather than weeks.

Is DBS for Parkinson's worth it? Weighing it against the alternatives

“Worth it” is a personal calculation, and no clinician can make it for someone else. What a good team can do is lay out the ledger clearly.

On one side sits a surgical procedure on the brain with a small but real risk of bleeding, infection and lasting side effects, several months of programming visits, hardware that needs occasional replacement, and no effect on disease progression. On the other sits the prospect of more predictable mobility, less tremor, fewer involuntary movements and, often, a simpler medication schedule. Randomized trials in advanced Parkinson’s, summarized by NIH, have found DBS plus medication to improve motor function and quality of life more than medication alone for selected patients, at the price of more adverse events. The NHS states plainly that DBS is not suitable for everyone and does not help all symptoms.

The alternatives deserve a fair hearing in the same conversation.

• Optimized medication. Adding or rearranging drug classes such as dopamine agonists, enzyme inhibitors or extended-release formulations can buy meaningful time for some people. This is always the first step.
• Infusion therapies. Continuous delivery of medication by pump, under the skin or into the gut, smooths fluctuations without brain surgery. Availability varies by country and the decision rests with a specialist team.
• Focused ultrasound. A non-incisional technique that uses converging sound waves to destroy a tiny area of tissue, usually the thalamus, to treat tremor on one side of the body. Mayo Clinic describes it as an option for essential tremor and tremor-dominant Parkinson’s; it is irreversible and generally done on one side only.
• Lesioning surgery. The older approach of destroying tissue with heat or radiation. Still used in some settings, particularly where hardware follow-up is impractical.

The question people find most useful is not “Is DBS good?” but “What specific problem in my week would I most want changed, and is it one stimulation reliably affects?” A team that answers that honestly is doing its job.

What are the deep brain stimulation side effects and risks?

Risks fall into three groups, and separating them helps because they behave differently: some are permanent, some are fixable with a programmer, and some are mechanical.

Surgical risks are the ones that cannot be undone. MedlinePlus and Mayo Clinic list bleeding in the brain, which can cause stroke-like deficits; infection at the scalp or chest, which may require removing the hardware and reimplanting later; seizures around the time of surgery; and, rarely, death. Confusion or delirium in the days after surgery is more common in older adults and usually resolves. Neither source gives figures that apply across all centers, and any specific percentage should come from the operating team’s own audited results.

Stimulation-related side effects arise when current spreads to neighboring structures, and they typically appear or vanish within seconds of changing settings. They include tingling or numbness, muscle tightening in the face or hand, slurred or quiet speech, double vision, dizziness, imbalance and, in some people, mood changes such as low mood, apathy or unusual euphoria. Impulsive behavior can emerge, often intertwined with medication changes. Because these effects are adjustable, an unpleasant one is a reason to call the programming clinic, not a verdict.

Hardware problems include lead movement or breakage, extension wire fracture from repetitive neck motion, skin erosion over the generator in thin individuals, and battery depletion. Each usually needs a minor procedure to correct. A sudden return of symptoms is the classic clue that a wire or battery has failed.

Weight gain of several kilograms is reported in a proportion of people after DBS for Parkinson’s, likely from reduced dyskinesia and energy expenditure. Some people also describe a period of low mood or a sense of loss even when motor symptoms improve; teams increasingly screen for this and offer support.

What people often get wrong about deep brain stimulation for movement disorders

Years of explaining this procedure produce a familiar set of misconceptions. Correcting them early saves grief later.

“It’s a last resort.” Historically DBS was reserved for very advanced disease. Evidence summarized by NIH from trials in people with earlier motor complications shifted that thinking, and many teams now consider it once fluctuations become troublesome rather than after every other option has failed. Timing is individualized, and “too early” is as real a risk as “too late.”

“It replaces medication.” Most people with Parkinson’s continue some medication after DBS, often at a lower dose set by their prescriber. Essential tremor and dystonia patients may be able to stop certain drugs, but that is a decision made with the clinician over months.

“Once it’s on, the work is done.” Programming is a relationship, not an event. Settings drift as disease and medication change, and batteries need replacing. Access to a programming clinic for the long term is part of the decision.

“It’s experimental.” DBS for Parkinson’s, essential tremor and dystonia is established and widely regulated. Uses for other conditions are a different matter and should be described as investigational when they are.

“It will help my walking and balance.” Sometimes, when those problems are driven by stiffness or slowness. Often not, when they stem from circuits levodopa never reached. This is the most common gap between hope and outcome.

“Being awake means feeling the surgery.” The scalp is numbed and the brain has no pain receptors. People describe pressure and noise, not pain, and many centers now offer the procedure asleep.

“A famous person had it, so it must be right for me.” Public figures’ choices reflect their own disease stage and era of treatment. Michael J. Fox, for instance, has publicly described a thalamotomy, a lesioning procedure, not DBS.

Questions to ask your care team

Consultations run short and memories run shorter. Writing questions down beforehand, and bringing someone to take notes, changes what people get out of the conversation. These are the ones experienced patients wish they had asked.

• Which of my symptoms do you expect stimulation to improve, which do you expect it to leave unchanged, and which might it worsen?
• Which target are you proposing, on one side or both, and why that choice for me specifically?
• Will I be awake or asleep for lead placement, and how do you decide?
• Will the leads and the generator be implanted in one operation or two?
• How many programming visits should I plan for in the first six months, and who does the programming if my usual clinician is unavailable?
• What is your team’s own rate of bleeding, infection and hardware revision, and how many of these procedures does the team perform each year?
• What happens to my medication after surgery, who manages the changes, and how quickly?
• How will you monitor my mood, memory and speech before and after surgery?
• Rechargeable or non-rechargeable generator: what are the trade-offs for someone with my lifestyle and dexterity?
• Can I have MRI scans in future with this system, and what do I need to tell other doctors and dentists?
• If the device does not help as hoped, what are the options, including turning it off or removing it?
• What would make you advise waiting, and what would prompt you to revisit the decision?
• Which alternatives, such as focused ultrasound or infusion therapy, did you consider for me, and why did you rank them as you did?

A team that welcomes this list is telling you something about how it will treat you over the decade of follow-up that comes next.

When to call your doctor

Most recoveries are uneventful, and most device issues are minor. A few situations should prompt an urgent call to the surgical or programming team, or emergency care if the team cannot be reached.

Seek emergency care immediately for sudden weakness or numbness on one side of the body, sudden difficulty speaking or understanding speech, a severe new headache, a seizure, sudden loss of vision, or new confusion or unresponsiveness. In the days after surgery these can signal bleeding in the brain; at any point afterward they can signal a stroke unrelated to the device, and either way minutes matter.

Call the team the same day for:

• Redness, warmth, swelling, pus or opening of any incision, or a fever without another obvious cause. Infection around the hardware needs prompt assessment.
• A sudden return of tremor, stiffness or dystonia after a period of good control, which may mean the battery has depleted or a wire has failed.
• New or worsening slurred speech, double vision, pulling sensations in the face or limb, or unsteadiness that began after a settings change.
• Marked changes in mood, thinking or behavior, including low mood, thoughts of self-harm, unusual impulsivity or agitation. Family members often notice these first and should feel free to call on the person’s behalf.
• Difficulty swallowing, choking on food or liquids, or unexplained weight loss.
• Skin thinning or breakdown over the generator or along the wire in the neck.

Keep the device identification card and the programming clinic’s contact number together, and make sure anyone who might accompany you to hospital knows where they are. People with DBS should tell every clinician, including dentists and imaging staff, about the implant before any procedure. When in doubt, call; programming teams would far rather hear about a false alarm than miss a real one.

Frequently asked questions

Can deep brain stimulation help with dyskinesia?

Yes, for many people with Parkinson’s disease, though not for everyone. Stimulation of the globus pallidus interna suppresses dyskinesia directly, while stimulation of the subthalamic nucleus works indirectly by improving the symptoms levodopa treats, allowing the prescribing clinician to gradually reduce medication. Any medication change must be made by the treating team over months; reducing drugs too quickly can cause severe stiffness or a dangerous withdrawal state.

What are the new treatments for dystonia?

Established options remain botulinum toxin injections for focal dystonia, oral medicines, and DBS of the globus pallidus interna for generalized or medication-resistant forms. Newer directions under study include stimulation systems that sense brain signals and adjust automatically, refined lead designs that shape current more precisely, focused ultrasound for selected tremor-dominant cases, and gene-guided selection, since certain inherited dystonias respond more predictably. None of these should be described as proven beyond the established options.

Is DBS for Parkinson's worth it?

It depends on which symptoms trouble you most and how they respond to levodopa. Trials summarized by NIH found DBS plus medication improved motor function and quality of life more than medication alone in selected people with motor fluctuations, with more adverse events. It does not slow the disease or reliably help balance, speech or memory. The answer emerges from an honest conversation with a specialist team about your priorities and risks.

Did Michael J. Fox have deep brain stimulation for Parkinson's?

No. He has publicly described undergoing a thalamotomy, a procedure that destroys a small area of the thalamus to reduce tremor on one side, rather than DBS. Lesioning procedures preceded DBS and are irreversible, whereas DBS is adjustable and reversible. A public figure’s treatment reflects their own disease pattern and the options available at the time, and offers little guidance about what suits any other person.

How does DBS for essential tremor work, and how well?

For essential tremor the lead is placed in the ventral intermediate nucleus of the thalamus, a relay that carries movement signals toward the cortex. Continuous stimulation disrupts the rhythmic firing that drives the shake, often reducing hand tremor visibly during the first programming visit. Head and voice tremor respond less predictably, and some people notice benefit fading over years, requiring reprogramming. Mayo Clinic describes it as an established option when medicines fail.

How long does DBS surgery take, and how long is the hospital stay?

Lead placement typically takes several hours, with the generator implanted the same day or in a second short operation a week or two later. Cleveland Clinic’s patient guidance describes a hospital stay of about one to two days after lead placement, followed by a couple of weeks of wound care at home. The device is usually activated a few weeks later, once swelling has settled, and programming continues over months.

Will I be awake during DBS surgery?

Possibly, depending on the center and your circumstances. Many programs keep patients awake for lead placement so the team can test stimulation and watch symptoms respond; the scalp is numbed and the brain has no pain receptors, so people describe pressure and noise rather than pain. Other programs perform the whole procedure under general anesthesia with real-time imaging. Mainstream guidance does not show one approach to be clearly superior for everyone.

Can I have an MRI scan with a deep brain stimulator?

Often yes, but only under specific conditions set for your particular system, which may include limits on scanner strength, body region and device settings. Some older systems restrict MRI more tightly. Carry your device identification card, tell every clinician and imaging technician about the implant before any scan, and ask the programming team to confirm the conditions in writing so other hospitals can follow them safely.

What are the most common deep brain stimulation side effects?

Stimulation-related effects such as tingling, muscle pulling, slurred or quiet speech, double vision, dizziness and mood changes are the most frequent, and they usually appear or resolve within seconds of adjusting settings, so they are correctable. Surgical risks are less common but more serious: bleeding, infection and seizures. Hardware problems like lead fracture or battery depletion typically present as a sudden return of symptoms and need a minor procedure.

Does deep brain stimulation stop Parkinson's from getting worse?

No. DBS treats symptoms by overriding abnormal signaling; it does not protect brain cells or slow the underlying disease, as NIH’s Parkinson’s resources make clear. Symptoms that respond to stimulation typically remain improved for years, but features that were absent at surgery, particularly balance problems, speech changes and cognitive decline, may emerge as the disease progresses. Ongoing programming and medication management with the treating team remain necessary.

References

• Cleveland Clinic: Deep Brain Stimulation (DBS)
• NHS: Parkinson's disease: Treatment
• NIH National Institute of Neurological Disorders and Stroke: Parkinson's Disease
• MedlinePlus: Deep brain stimulation

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.